$
66.500
+0.4(0.605%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
66.960
Open
66.360
VWAP
66.55
Vol
1.12M
Mkt Cap
14.82B
Low
65.610
Amount
74.31M
EV/EBITDA(TTM)
12.28
Total Shares
233.38M
EV
15.73B
EV/OCF(TTM)
13.90
P/S(TTM)
3.84
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
1.07B
+4.65%
1.083
+5.15%
1.03B
+4.68%
1.083
+7.18%
1.01B
-0.54%
1.063
+0.27%
Estimates Revision
The market is revising Downward the revenue expectations for Hologic, Inc. (HOLX) for FY2025, with the revenue forecasts being adjusted by -0.21% over the past three months. During the same period, the stock price has changed by 14.50%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.21%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-1.82%
In Past 3 Month
Stock Price
Go Up
up Image
+14.50%
In Past 3 Month
15 Analyst Rating
up Image
1.71% Upside
Wall Street analysts forecast HOLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HOLX is 67.64 USD with a low forecast of 60.00 USD and a high forecast of 71.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
9 Hold
0 Sell
Moderate Buy
up Image
1.71% Upside
Current: 66.500
sliders
Low
60.00
Averages
67.64
High
71.00
Mizuho
Outperform
upgrade
$65 -> $70
2025-07-16
Reason
Mizuho raised the firm's price target on Hologic to $70 from $65 and keeps an Outperform rating on the shares. The firm adjusted price targets in medical devices and diagnostics ahead of the Q2 reports.
Citi
Neutral -> Buy
upgrade
$60 -> $80
2025-07-09
Reason
Citi upgraded Hologic to Buy from Neutral with a price target of $80, up from $60. The firm says the as a recent potential buyout report has increased interest in the the shares while fiscal 2025 estimates are reasonable. Street estimates are now appropriately reflecting the current demand trends and possible tariff implications, while Hologic shares are trading at a discount to both historical averages and the peer group, the analyst tells investors in a research note.
Stephens
Overweight
downgrade
$77 -> $70
2025-05-13
Reason
Citigroup
Patrick Donnelly
Hold
Maintains
$80 → $70
2025-03-04
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-02-06
Reason
Leerink Partners
Puneet Souda
Buy
to
Hold
Downgrades
$80 → $75
2025-02-06
Reason

Valuation Metrics

The current forward P/E ratio for Hologic Inc (HOLX.O) is 15.53, compared to its 5-year average forward P/E of 17.34. For a more detailed relative valuation and DCF analysis to assess Hologic Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
17.34
Current PE
15.53
Overvalued PE
21.24
Undervalued PE
13.45

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
12.83
Current EV/EBITDA
11.49
Overvalued EV/EBITDA
15.26
Undervalued EV/EBITDA
10.39

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
4.27
Current PS
3.54
Overvalued PS
4.81
Undervalued PS
3.72

Financials

Annual
Quarterly
FY2025Q2
YoY :
-1.23%
1.01B
Total Revenue
FY2025Q2
YoY :
-5.01%
231.10M
Operating Profit
FY2025Q2
YoY :
-110.24%
-17.40M
Net Income after Tax
FY2025Q2
YoY :
-111.11%
-0.08
EPS - Diluted
FY2025Q2
YoY :
-51.13%
129.20M
Free Cash Flow
FY2025Q2
YoY :
+0.24%
55.40
Gross Profit Margin - %
FY2025Q2
YoY :
+0.54%
24.09
FCF Margin - %
FY2025Q2
YoY :
-110.37%
-1.73
Net Margin - %
FY2025Q2
YoY :
+25.77%
9.03
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
1.9M
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
1
300.8K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 4616.24% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
20.7K
Volume
1
6-9
Months
408.8K
Volume
4
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
7
2.9M
Volume
Months
6-9
3
62.3K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress areSelling! The selling amount has increased368.75%over the last month.
Sold
0-3
Months
75.0K
USD
1
3-6
Months
16.0K
USD
2
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

HOLX News & Events

Events Timeline

2025-06-27 (ET)
2025-06-27
11:48:28
USPSTF ruling 'marks the turn' for Exact Sciences shares, says Evercore ISI
select
2025-05-28 (ET)
2025-05-28
09:55:02
Early notable gainers among liquid option names on May 28th
select
2025-05-27 (ET)
2025-05-27
14:13:36
Takeout offer validates Hologic at attractive valuation, says Raymond James
select
Sign Up For More Events

News

3.0
07-25NASDAQ.COM
HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now?
4.0
07-16Benzinga
Mizuho Maintains Outperform on Hologic, Raises Price Target to $70
3.0
07-10NASDAQ.COM
Guru Fundamental Report for HOLX
Sign Up For More News

FAQ

arrow icon

What is Hologic Inc (HOLX) stock price today?

The current price of HOLX is 66.5 USD — it has increased 0.61 % in the last trading day.

arrow icon

What is Hologic Inc (HOLX)'s business?

arrow icon

What is the price predicton of HOLX Stock?

arrow icon

What is Hologic Inc (HOLX)'s revenue for the last quarter?

arrow icon

What is Hologic Inc (HOLX)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Hologic Inc (HOLX)'s fundamentals?

arrow icon

How many employees does Hologic Inc (HOLX). have?

arrow icon

What is Hologic Inc (HOLX) market cap?